Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

INDUSTRY 16 OTHER 13 NIH 3 OTHER_GOV 1 FED 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Estrogen Receptor Positive Breast Cancer 1

Interventions

Capecitabine 9 Bevacizumab 8 tislelizumab 7 Oxaliplatin 7 Drug Therapy 7 pembrolizumab 6 Surgical Procedures, Operative 6 Cisplatin 6 Standard of Care 5 Radiotherapy 5 Laparoscopy 5 Fluorouracil 5 Docetaxel 5 Carboplatin 5 toripalimab 4 Radiosurgery 4 Leucovorin 4 Exercise 4 Epirubicin 4 Cyclophosphamide 4 pertuzumab 3 durvalumab 3 dalpiciclib 3 atezolizumab 3 anlotinib 3 Saline Solution 3 Rituximab 3 Radiation 3 Prednisone 3 Population Groups 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER_GOV × capivasertib × 1 year × Clear all

NCT01992952 2025-11-26

FAKTION

Velindre NHS Trust

Phase 1/2 Active not recruiting

Estrogen Receptor Positive Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡